Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis
Journal of the American Heart Association · 05.05.2026 · 15 (9)
DOI: 10.1161/jaha.125.047119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 05.05.2026. Verfasst von Naoya Kuwahara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan. Hauptthemen laut MEDLINE: Fibroblasts, Heart Failure, Myocardium, C-Reactive Protein. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cardiac fibrosis is a hallmark of heart failure and can be quantified by the extracellular volume fraction (ECV) derived from diagnostic imaging. However, noninvasive assessment is limited by the lack of specific circulating biomarkers. Recent large plasma proteome analyses have identified SVEP1 (Sushi, von Willebrand factor type A, EGF, and pentraxin domain containing 1) as candidate molecules reflecting cardiac fibrosis. This study aimed to evaluate SVEP1 as a biomarker for cardiac fibrosis.
Methods
In 72 patients with heart failure due to aortic stenosis, computed tomography‐based ECV, serum SVEP1, and BNP (brain natriuretic peptide) levels were assessed. Multivariable regression was used to determine independent predictors of ECV. Publicly available single‐nucleus RNA sequencing of human hearts revealed the cellular origin of SVEP1 . SVEP1 secretion was assessed in human cardiac fibroblasts after TGF‐β (transforming growth factor‐β) stimulation or small interfering RNA knockdown. Plasma Svep1 and cardiac hydroxyproline levels were measured in mice with angiotensin II‐ and phenylephrine‐induced cardiac fibrosis.
Results
Serum SVEP1 correlated with ECV and outperformed BNP in detecting fibrosis. Multivariable analysis revealed SVEP1 as an independent predictor of ECV. In addition, snRNA‐seq revealed fibroblast‐specific expression, expanded in failing hearts consistent with activated fibroblast emergence. Furthermore, TGF‐β increased SVEP1 secretion in human cardiac fibroblasts, whereas its knockdown reduced SVEP1 secretion. Plasma Svep1 and cardiac hydroxyproline levels were elevated and positively correlated in mice.
Conclusions
Compared with BNP, SVEP1, derived from cardiac fibroblasts, is more strongly associated with ECV‐defined fibrosis and may serve as a novel fibrosis‐specific circulating biomarker in heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.
- Division of Evidence-based Laboratory Medicine Kobe University Graduate School of Medicine Kobe Japan.
- Department of Radiology Kobe University Graduate School of Medicine Kobe Japan.
- Division of Advanced Medical Science Kobe University Graduate School of Science, Technology and Innovation Kobe Japan.
- Division of Nursing Practice Kobe University Graduate School of Health Sciences Kobe Japan.
- Division of Molecular Epidemiology Kobe University Graduate School of Medicine Kobe Japan.
ORCID-Profile: Naoya Kuwahara, Manabu Nagao, Yu Izawa, Kenta Kaneshiro, Hiromi Hashimura, Takuo Emoto, Takayoshi Toba, Hidekazu Tanaka, Tatsuro Ishida, Masakazu Shinohara, Hiromasa Otake
Zitieren
APA
Kuwahara, N., Nagao, M., Izawa, Y., Kaneshiro, K., Hashimura, H., Yoshida, T., Emoto, T., Toba, T., Tanaka, H., Ishida, T., Shinohara, M., & Otake, H. (2026). Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis. Journal of the American Heart Association, 15(9). https://doi.org/10.1161/jaha.125.047119
Vancouver
Kuwahara N, Nagao M, Izawa Y, Kaneshiro K, Hashimura H, Yoshida T, et al. Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis. Journal of the American Heart Association. 2026;15(9). doi:10.1161/jaha.125.047119
BibTeX
@article{Kuwahara2026,
author = {Kuwahara, Naoya and Nagao, Manabu and Izawa, Yu and Kaneshiro, Kenta and Hashimura, Hiromi and Yoshida, Takeshi and Emoto, Takuo and Toba, Takayoshi and Tanaka, Hidekazu and Ishida, Tatsuro and Shinohara, Masakazu and Otake, Hiromasa},
title = {Sushi, von Willebrand Factor Type A, EGF and Pentraxin Domain‐Containing Protein 1: A Novel Fibroblast‐Derived Circulating Biomarker Reflecting Cardiac Fibrosis},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {9},
doi = {10.1161/jaha.125.047119}
}
EUVIMED